Bleomycin and disease progression Patient Reports February 11, 2012
Bleomycin Side Effects Report #5272656-5
Bleomycin side effect was reported by a Health Professional from AUSTRALIA on Mar 20, 2007. Male patient, 27 years of age, was diagnosed with retroperitoneal cancer and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure, shock. Bleomycin dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, IFOSFAMIDE, PACLITAXEL, PIPERACILLIN, TAZOBACTAM, NITROUS OXIDE W. Patient was hospitalized. Patient recovered.
Bleomycin Side Effects Report #5009126-5
Bleomycin side effect was reported by a Health Professional from FRANCE on May 08, 2006. Male patient, 45 years of age, was diagnosed with hodgkin's disease
and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, hypoxia, interstitial lung disease, lung disorder, pulmonary fibrosis
, pyrexia, respiratory disorder. Bleomycin dosage: 19 MG IV. Patient was hospitalized. Patient died on 03/31/2006.Bleomycin Side Effects Report #5009217-9
Bleomycin side effect was reported by a Consumer or non-health professional from FRANCE on May 08, 2006. Male patient, 45 years of age, was diagnosed with hodgkin's disease
and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, lung disorder, pulmonary fibrosis
. Bleomycin dosage: 19 MG IV. Patient was hospitalized. Patient died on 03/31/2006.Bleomycin Side Effects Report #5288621-8
Bleomycin side effect was reported by a Physician from POLAND on Mar 19, 2007. Male patient, 25 years of age, was diagnosed with hodgkin's disease
and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disease progression, hodgkin's disease
, immunosuppression, interstitial lung disease, lung neoplasm, lymphadenopathy, sarcoidosis, treatment noncompliance. Bleomycin dosage: unknown. During the same period patient was treated with DACARBAZINE, DOXORUBICIN, VINBLASTINE SULPHATE, VINBLASTINE SULPHATE, CORTICOSTEROID. Patient recovered.Bleomycin Side Effects Report #4757809-4
Bleomycin side effect was reported by a Physician from GERMANY on Aug 16, 2005. Male patient, 39 years of age, was treated with Bleomycin. After drug was administered, patient experienced the following side effects: blast cell crisis, bone pain, disease progression, feeling abnormal, headache
, nausea
. Bleomycin dosage: 30 MG ONCE IT. Patient recovered.Bleomycin Side Effects Report #5931044-6
Bleomycin side effect was reported by a Consumer or non-health professional from ITALY on Oct 06, 2008. Male patient was treated with Bleomycin. After drug was administered, patient experienced the following side effects: abnormal behaviour, asthenia, chloroma, coma, confusional state, depressed level of consciousness, disease progression, disorientation, haemorrhage. Bleomycin dosage: 30 MG; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient died.
Bleomycin and disease progression 